Disease areas:
  • nutrition and metabolism
Last updated:
Author(s):
Xiaonan Liu, Thomas J Littlejohns, Jelena Bešević, Fiona Bragg, Lei Clifton, Jennifer A Collister, Eirini Trichia, Laura J Gray, Kamlesh Khunti, David J Hunter
Publish date:
29 March 2024
Journal:
Diabetes & Metabolic Syndrome Clinical Research & Reviews
PubMed ID:
38608567

Abstract

AIMS: We evaluated whether incorporating information on ethnic background and polygenic risk enhanced the Leicester Risk Assessment (LRA) score for predicting 10-year risk of type 2 diabetes.

METHODS: The sample included 202,529 UK Biobank participants aged 40-69 years. We computed the LRA score, and developed two new risk scores using training data (80% sample): LRArev, which incorporated additional information on ethnic background, and LRAprs, which incorporated polygenic risk for type 2 diabetes. We assessed discriminative and reclassification performance in a test set (20% sample). Type 2 diabetes was ascertained using primary care, hospital inpatient and death registry records.

RESULTS: Over 10 years, 7,476 participants developed type 2 diabetes. The Harrell’s C indexes were 0.796 (95% Confidence Interval [CI] 0.785, 0.806), 0.802 (95% CI 0.792, 0.813), and 0.829 (95% CI 0.820, 0.839) for the LRA, LRArev and LRAprs scores, respectively. The LRAprs score significantly improved the overall reclassification compared to the LRA (net reclassification index [NRI] = 0.033, 95% CI 0.015, 0.049) and LRArev (NRI = 0.040, 95% CI 0.024, 0.055) scores.

CONCLUSIONS: Polygenic risk moderately improved the performance of the existing LRA score for 10-year risk prediction of type 2 diabetes.

Related projects

The development of polygenic risk scores enables risk stratification for individual cancers. These have been developed by international consortia. The purpose of this research is…

Institution:
University of Oxford, Great Britain

All projects